Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2021-01-05 19:09:33
Reporting Period:
Accepted Time:
2021-01-05 19:09:33
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
318306 Abeona Therapeutics Inc. ABEO Pharmaceutical Preparations (2834) 830221517
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1642715 Todd Wider 1330 Avenue Of The Americas, 33Rd Floor
New York NY 10019
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-31 609,755 $0.00 310,501 No 4 D Direct
Common Stock Disposition 2021-01-04 33,876 $1.54 276,625 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 D Direct
No 4 S Direct
  1. Represents unvested shares of restricted common stock granted to the reporting person on October 8, 2020 in connection with the formation of a special committee of the Issuer's board of directors as reported on Form 8-K on October 6, 2020. These shares were scheduled to vest in monthly installments only while the special committee was operational and the reporting person was providing service to the special committee; the special committee was dissolved on December 31, 2020. The reporting person continues to serve on the Issuer's board of directors.
  2. The sales reported in this Form 4 were to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 19, 2020.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.50 to $1.575, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.